Karyopharm Therapeutics
Karyopharm Therapeutics Inc. is an oncology-focused biopharmaceutical company focused on the discovery, development and commercialization of novel medicines. Learn more
Launch date
Employees
Market cap
CAD130m
Enterprise valuation
CAD189m (Public information from Sep 2024)
Share price
$0.737 KPTI
Newton Massachusetts (HQ)
Authorizing premium user...